F. K. Jansen
Impact in
- Biotechnology top 0.5%
- Transgenic Plants and Applications
- Microbial Inactivation Methods
- Immunology top 2%
- Toxin Mechanisms and Immunotoxins
Papers in
- Immunology 29
- Toxin Mechanisms and Immunotoxins 25
-
- Transgenic Plants and Applications 17
- Microbial Inactivation Methods 4
- Co-authors
- Pierre Casellas (15 shared papers)Pierre Gros (10 shared papers)Hubert Vidal (10 shared papers)H. Blythman (6 shared papers)Olivier Gros (5 shared papers)B. Bourrié (3 shared papers)Bernard Pau (3 shared papers)F Paolucci (3 shared papers)
- Journals
- Diabetologia (4 papers)Journal of Biological Chemistry (3 papers)Cancer treatment and research (3 papers)Leukemia Research (2 papers)Nature (2 papers)
- Partner nations
- FranceGermanyUnited States
In The Last Decade
F. K. Jansen
43 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 81
- Biotechnology 652
- Immunology 972
- Radiology, Nuclear Medicine and Imaging 355
- Toxicology 44
- Molecular Biology 498
Countries citing papers authored by F. K. Jansen
This map shows the geographic impact of F. K. Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. K. Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. K. Jansen more than expected).
Fields of papers citing papers by F. K. Jansen
This network shows the impact of papers produced by F. K. Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. K. Jansen. The network helps show where F. K. Jansen may publish in the future.
Co-authors
The 25 scholars most cited alongside F. K. Jansen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1981 | 192 | |
| 2 | 1984 | 177 | |
| 3 | 1982 | 136 | |
| 4 | 1986 | 100 | |
| 5 | 1982 | 87 | |
| 6 | A phase I study of T101-ricin A chain immunotoxin in refractory chronic lymphocytic leukemia. | 1988 | 58 |
| 7 | 1976 | 50 | |
| 8 | Determination of sensitivity of fresh leukemia cells to immunotoxins. | 1986 | 49 |
| 9 | 1969 | 43 | |
| 10 | 1980 | 40 | |
| 11 | 1977 | 36 | |
| 12 | 1985 | 34 | |
| 13 | Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model. | 1985 | 32 |
| 14 | 1988 | 29 | |
| 15 | 1998 | 28 | |
| 16 | Kinetics of Cytotoxicity Induced by Immunotoxins | 1984 | 27 |
| 17 | 1966 | 27 | |
| 18 | 1985 | 19 | |
| 19 | 1987 | 15 | |
| 20 | 1988 | 13 |
About F. K. Jansen
F. K. Jansen is a scholar working on Immunology, Biotechnology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 48 papers that have together received 1.3k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (25 papers), Transgenic Plants and Applications (17 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Diabetes and associated disorders (8 papers), Quantum Mechanics and Applications (6 papers), Biofield Effects and Biophysics (5 papers), Plant tissue culture and regeneration (5 papers) and Microbial Inactivation Methods (4 papers). The work is most often cited by research in Biotechnology (652 citations), Immunology (972 citations), Radiology, Nuclear Medicine and Imaging (355 citations), Toxicology (44 citations) and Molecular Biology (498 citations). F. K. Jansen has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Pierre Casellas, Pierre Gros, Hubert Vidal, H. Blythman, Olivier Gros, B. Bourrié, Bernard Pau, F Paolucci, Bernard Bourrié and R Kinský. Their work appears in journals such as Diabetologia, Journal of Biological Chemistry, Cancer treatment and research, Leukemia Research and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.